Coleman Mark — SEC Form 4 filings
SEC reporting owner CIK 1658379. 15 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-05-29 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 1 filing — 1,575 shares, $200,466 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 10 legs across 6 filings — 64,177 shares, $10,102,283 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 25,000 shares @ $161.11 ($4,027,750) in Axsome Therapeutics, Inc., filed 2026-02-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Director | 15 | 3 legs · 1,575 sh · $200,466 | 10 legs · 64,177 sh · $10,102,283 | 16 |
Form 4 filings — Coleman Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 1,429 · Sale (S): 643 @ $249 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 6,000 @ $233.46 · Sale (S): 6,000 @ $230.30 · Sale (S): 5,537 @ $223.39 | EDGAR |
| 2026-02-27 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 25,000 @ $161.11 | EDGAR |
| 2026-02-25 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 6,250 @ $4.95 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 12,485 @ $4.95 · Option exercise (M): 12,485 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 5,193 @ $8.02 · Option exercise (M): 5,193 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Axsome Therapeutics, Inc. (AXSM) | Purchase (P): 800 @ $127.20 · Purchase (P): 287 @ $127.30 · Purchase (P): 488 @ $127.40 | EDGAR |
| 2025-06-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 3,166 (derivative) @ $0 · Grant/award (A): 1,429 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 3,750 @ $105.47 · Sale (S): 3,750 @ $103.43 | EDGAR |
| 2025-05-20 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 3,000 @ $107.49 | EDGAR |
| 2025-01-06 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 9,127 @ $9 · Option exercise (M): 9,127 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 33,410 @ $5.94 · Option exercise (M): 33,410 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 5,799 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Axsome Therapeutics, Inc. (AXSM) | Sale (S): 5,249 @ $75.21 · Sale (S): 5,248 @ $75.14 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1658379 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →